Tango Therapeutics Income Statement (2020-2026) | TNGX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.00B	0.01B	0.00B	0.05B
Operating items
Research & Development (Quarter)	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.04B	0.04B	0.03B	0.03B	0.04B	0.03B	0.03B	0.03B	0.03B
Selling, General & Administrative (Quarter)	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B
Other Operating Expenses (Quarter)														-0.04B	0.12B	-0.04B				-0.04B
Operating Expenses (Quarter)	0.02B	0.03B	0.03B	0.03B	0.03B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.05B	0.05B	0.01B	0.17B	0.01B	0.04B	0.04B	0.04B	0.01B
Operating Income (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.03B	-0.03B	-0.03B	-0.03B	-0.02B	-0.03B	-0.04B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.01B	-0.04B	-0.05B
EBIT (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.03B	-0.03B	-0.03B	-0.03B	-0.02B	-0.03B	-0.04B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.01B	-0.04B	-0.05B
Non-operating items
Non Operating Investment Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B
Interest & Investment Income (Quarter)	0.00B
Other Non Operating Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Non Operating Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Net income details
EBT (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.03B	-0.03B	-0.02B	-0.02B	-0.03B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.02B	-0.04B	-0.05B
Tax Provisions (Quarter)	-0.00B	0.00B	0.00B		0.00B		0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B
Profit After Tax (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.02B	-0.03B	-0.02B	-0.02B	-0.03B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.02B	-0.04B	-0.05B
Income from Continuing Operations (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.03B	-0.03B	-0.02B	-0.02B	-0.03B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.02B	-0.04B	-0.05B
Consolidated Net Income (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.03B	-0.03B	-0.02B	-0.02B	-0.03B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.02B	-0.04B	-0.05B
Income towards Parent Company (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.03B	-0.03B	-0.02B	-0.02B	-0.03B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.02B	-0.04B	-0.05B
Net Income towards Common Stockholders (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.02B	-0.03B	-0.03B	-0.03B	-0.02B	-0.02B	-0.03B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.02B	-0.04B	-0.05B
Additional items
EPS (Basic) (Quarter)	-0.27	-0.28	-0.35	-0.29	-0.28	-0.33	-0.33	-0.32	-0.23	-0.23	-0.32	-0.35	-0.24	-0.27	-0.34	-0.36	-0.35	0.14	-0.33	-0.32
EPS (Diluted) (Quarter)	-0.09	-0.28	-0.35	-0.29	-0.28	-0.33	-0.33	-0.32	-0.23	-0.23	-0.32	-0.35	-0.24	-0.27	-0.34	-0.36	-0.35	0.13	-0.33	-0.32
Shares Outstanding (Quarter)	0.02B	0.07B	0.06B	0.09B	0.09B	0.09B	0.09B	0.09B	0.09B	0.10B	0.09B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.12B	0.14B
Shares Outstanding (Diluted) (Quarter)	0.05B	0.07B	0.06B	0.09B	0.09B	0.09B	0.09B	0.09B	0.09B	0.10B	0.09B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.12B	0.12B	0.14B
EBITDA (Quarter)	-0.00B	-0.02B	-0.02B	-0.03B	-0.03B	-0.03B	-0.03B	-0.03B	-0.02B	-0.03B	-0.04B	-0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	0.01B	-0.04B	-0.05B
Interest Expenses (Quarter)		69.73B	0.05B	27.14B	9.64B	4.91B	0.08B	6.44B	3.77B	87.90B	0.06B	0.04B	0.04B	0.03B	0.00B	0.00B	0.02B	0.06B	0.06B	0.31B
Tax Rate (Quarter)	0.47%	-0.32%	-0.81%		-0.01%		-0.33%		-0.48%	-0.10%	-0.04%	-0.11%	-0.26%	-0.19%	-0.13%	-0.09%	-0.09%	-0.06%	0.14%	0.00%

Research Tools

Developers

Tango Therapeutics Income Statement (2020-2026) | TNGX

Research Tools

Developers

Tango Therapeutics Income Statement (2020-2026) | TNGX

Create an account

Sign In

Reset Password